Treating Necrobiosis Lipoidica: What the Evidence Shows

More Heart Disease, Stroke and Diabetes Articles

Treating Necrobiosis Lipoidica: What the Evidence Shows

By Your Health Magazine Health Information Team

A reddish-brown patch on the shin may look like a bruise at first. Instead of fading, however, it slowly expands, develops a shiny yellow center, or becomes thin enough to break open after a minor bump. For people diagnosed with necrobiosis lipoidica, a common question is simple: What treatment actually works?

The honest answer is that necrobiosis lipoidica can be difficult to treat, and no single therapy works reliably for everyone. Research supports several reasonable approaches, but much of the evidence comes from case reports, small patient groups, and retrospective studies rather than large clinical trials. Treatment is therefore selected according to whether a lesion is actively inflamed, stable and scar-like, or ulcerated.

What Is Necrobiosis Lipoidica?

Necrobiosis lipoidica is an uncommon, long-lasting inflammatory skin disorder. It usually affects the shins, although lesions can occur elsewhere. Early spots may be red, brown, or purple and slightly raised. Over time, they may grow into smooth plaques with an inflamed border and a yellow-brown, shiny, thinned center. Visible small blood vessels are common.

The condition is strongly associated with diabetes, particularly type 1 diabetes, but it can also develop in people without diabetes. The older name “necrobiosis lipoidica diabeticorum,” or NLD, is still widely used. Because a skin condition that resembles NLD may have another cause, a dermatologist may recommend a skin biopsy when the appearance is unclear, an ulcer is present, or a lesion has suspicious changes.

What the Evidence Says About NLD Treatment

A recent systematic review found that the published treatment evidence is dominated by case reports, case series, and a small number of retrospective studies. This makes it difficult to compare therapies or predict an individual response. Treatment generally works better on an actively inflamed border than on an established center where the skin has already become thin and scar-like.

Observation and Skin Protection

A stable lesion that is not painful, spreading, or ulcerated may not require medication. Regular monitoring may be appropriate because treatment can cause side effects and may not reverse existing skin thinning or discoloration.

Protecting the area is an important part of care. Minor injuries can trigger an ulcer in fragile skin, so avoiding repeated friction, scratching, and direct knocks may help. A clinician may suggest a protective dressing or another barrier for activities that expose the shins to injury. Smoking cessation is also encouraged because smoking can interfere with wound healing.

Topical and Injected Medicines

Potent prescription corticosteroid creams or ointments are commonly used on the raised, actively inflamed edge of an early lesion. They may reduce inflammation and help limit expansion. These medicines require careful supervision because extended use can thin the skin. Applying them to an already atrophic center may worsen fragility and increase the risk of breakdown.

Topical tacrolimus, a calcineurin inhibitor, is another anti-inflammatory option. Its use for necrobiosis lipoidica is off-label, meaning it is not specifically approved for this condition. Published experience remains limited, but it may be considered when corticosteroid-related thinning is a concern. Corticosteroid injections into the inflamed border are sometimes used when topical therapy is insufficient, although injections can also contribute to skin thinning.

Compression and Light-Based Therapy

Compression therapy may reduce swelling and support healing when lesions affect the lower legs, especially if venous disease or edema is also present. Compression is not appropriate for everyone, so circulation should be evaluated before it is started.

Dermatologists may consider medically supervised ultraviolet therapy, including psoralen plus UVA, for persistent disease. Photodynamic therapy, which combines a light-sensitive medication with a controlled light source, has also helped some patients. Results vary, appointments can be time-consuming, and these procedures do not reliably restore skin that is already scarred or atrophic.

Systemic Treatment for Difficult Cases

Severe, spreading, painful, or ulcerated disease may lead a dermatologist to consider medicines that affect inflammation or immune activity. Published reports describe systemic corticosteroids, cyclosporine, fumaric acid esters, antimalarial medicines, tumor necrosis factor inhibitors, and Janus kinase inhibitors, among other therapies.

Most systemic options are off-label for necrobiosis lipoidica, and the strength of evidence varies considerably. They may also have important risks, including infection, changes in blood pressure or blood sugar, and effects on the liver, kidneys, blood cells, or immune system. The decision to use one requires specialist assessment and appropriate monitoring rather than a trial-and-error approach at home.

Treating an Ulcerated Lesion

When the thin center of a plaque breaks open, wound care becomes a priority. Treatment may include gentle cleansing, an appropriate dressing, pain management, protection from further trauma, and evaluation for infection or circulation problems. A wound care specialist may help manage ulcers that are deep, painful, draining, or slow to heal.

Hyperbaric oxygen therapy and surgical removal followed by skin grafting have been reported in selected severe cases, but the evidence is limited. Surgery can produce additional scarring, and lesions may recur, so it is generally reserved for carefully chosen situations after more conservative measures have failed.

Does Better Diabetes Control Clear NLD?

Improving blood glucose control is important for overall health and may support wound healing, but it does not consistently make necrobiosis lipoidica disappear. People with diabetes should continue working with their healthcare team to manage glucose, blood pressure, cholesterol, circulation, and other factors that may affect skin health. This overview of skin care and diabetes explains additional ways diabetes can influence everyday skin care.

People diagnosed with necrobiosis lipoidica who have not previously been evaluated for diabetes may be offered blood glucose testing. Depending on their history and symptoms, clinicians may also consider associated conditions such as thyroid disease or other autoimmune disorders. Readers looking for broader, government-reviewed health information can explore MedlinePlus health topics.

What Results Should You Expect?

The practical goal of NLD treatment is often to reduce active inflammation, slow enlargement, relieve pain or itching, prevent ulcers, and heal existing wounds. Complete clearing is not guaranteed. Even when inflammation settles, discoloration, visible blood vessels, or skin thinning may remain.

Because response is unpredictable, follow-up matters. Photographs taken under similar lighting can help document whether a lesion is expanding, becoming less inflamed, or developing an open area. Changes should be reviewed with the treating clinician rather than prompting unsupervised changes to prescription therapy.

When to Seek Care

Arrange an evaluation with a primary care clinician or dermatologist for a persistent, enlarging, shiny yellow-brown patch, especially on the shin. Seek prompt care if an existing lesion breaks open, becomes increasingly painful, develops warmth, spreading redness, swelling, drainage, or an unpleasant odor, or is accompanied by fever. A nonhealing ulcer, new lump, persistent scab, bleeding area, or rapid change within a longstanding plaque also needs timely dermatologic assessment because chronic lesions carry a rare risk of skin cancer.

A dermatologist usually directs NLD treatment. An endocrinologist or primary care professional may assist with diabetes and related health conditions, while a wound care or vascular specialist may be needed for ulceration, leg swelling, or concerns about circulation.